This trial represents a long overdue global public health milestone. IAVI’s is the only Lassa vaccine candidate to ever advance from Phase 1, which is typically used to study safety, onto Phase two, which is used to evaluate participants’ immune responses and other factors. Our ultimate goal is a Lassa vaccine that is affordable and accessible to all populations in need.
As a Kenyan scientist, I’m gratified that the search for a Lassa fever vaccine is being led by prominent scientists and community leaders on the continent. For the first time, I’m optimistic that such a future is not so far away. African leadership in this trial offers hope that achieving the continent’s vision for a New Public Health Order is within reach.
The political crisis rocking Rivers State appears not to be ending anytime soon as the incumbent chairmen of the 23 local government areas in the state, have vowed not to vacate office after the expiration of their tenure on June 17, 2024. The State Chapter of Association of Local Governments of Nigeria, legal adviser…
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: DailyPostNGR - 🏆 11. / 59 Read more »
Source: GuardianNigeria - 🏆 1. / 94 Read more »
Source: vanguardngrnews - 🏆 5. / 75 Read more »
Source: GuardianNigeria - 🏆 1. / 94 Read more »